rs1062651

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001282531.3(ADNP):​c.2568C>T​(p.Val856Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0294 in 1,613,998 control chromosomes in the GnomAD database, including 3,764 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.095 ( 1849 hom., cov: 33)
Exomes 𝑓: 0.023 ( 1915 hom. )

Consequence

ADNP
NM_001282531.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.48

Publications

11 publications found
Variant links:
Genes affected
ADNP (HGNC:15766): (activity dependent neuroprotector homeobox) Vasoactive intestinal peptide is a neuroprotective factor that has a stimulatory effect on the growth of some tumor cells and an inhibitory effect on others. This gene encodes a protein that is upregulated by vasoactive intestinal peptide and may be involved in its stimulatory effect on certain tumor cells. The encoded protein contains one homeobox and nine zinc finger domains, suggesting that it functions as a transcription factor. This gene is also upregulated in normal proliferative tissues. Finally, the encoded protein may increase the viability of certain cell types through modulation of p53 activity. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]
ADNP Gene-Disease associations (from GenCC):
  • ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 20-50892146-G-A is Benign according to our data. Variant chr20-50892146-G-A is described in ClinVar as Benign. ClinVar VariationId is 587839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.48 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADNPNM_001282531.3 linkc.2568C>T p.Val856Val synonymous_variant Exon 6 of 6 ENST00000621696.5 NP_001269460.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADNPENST00000621696.5 linkc.2568C>T p.Val856Val synonymous_variant Exon 6 of 6 5 NM_001282531.3 ENSP00000483881.1

Frequencies

GnomAD3 genomes
AF:
0.0945
AC:
14365
AN:
152016
Hom.:
1837
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.291
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0405
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.0187
Gnomad SAS
AF:
0.0321
Gnomad FIN
AF:
0.0151
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0157
Gnomad OTH
AF:
0.0745
GnomAD2 exomes
AF:
0.0369
AC:
9260
AN:
251074
AF XY:
0.0321
show subpopulations
Gnomad AFR exome
AF:
0.295
Gnomad AMR exome
AF:
0.0242
Gnomad ASJ exome
AF:
0.0204
Gnomad EAS exome
AF:
0.0213
Gnomad FIN exome
AF:
0.0125
Gnomad NFE exome
AF:
0.0150
Gnomad OTH exome
AF:
0.0275
GnomAD4 exome
AF:
0.0227
AC:
33114
AN:
1461864
Hom.:
1915
Cov.:
35
AF XY:
0.0218
AC XY:
15845
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.309
AC:
10338
AN:
33478
American (AMR)
AF:
0.0278
AC:
1245
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0189
AC:
494
AN:
26136
East Asian (EAS)
AF:
0.0144
AC:
572
AN:
39700
South Asian (SAS)
AF:
0.0277
AC:
2392
AN:
86254
European-Finnish (FIN)
AF:
0.0122
AC:
651
AN:
53400
Middle Eastern (MID)
AF:
0.0293
AC:
169
AN:
5768
European-Non Finnish (NFE)
AF:
0.0135
AC:
15050
AN:
1112008
Other (OTH)
AF:
0.0365
AC:
2203
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1867
3734
5601
7468
9335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0947
AC:
14403
AN:
152134
Hom.:
1849
Cov.:
33
AF XY:
0.0917
AC XY:
6820
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.291
AC:
12073
AN:
41444
American (AMR)
AF:
0.0404
AC:
617
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
65
AN:
3472
East Asian (EAS)
AF:
0.0188
AC:
97
AN:
5168
South Asian (SAS)
AF:
0.0317
AC:
153
AN:
4820
European-Finnish (FIN)
AF:
0.0151
AC:
160
AN:
10604
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0157
AC:
1068
AN:
68016
Other (OTH)
AF:
0.0742
AC:
157
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
540
1079
1619
2158
2698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0456
Hom.:
2139
Bravo
AF:
0.105
Asia WGS
AF:
0.0480
AC:
168
AN:
3478
EpiCase
AF:
0.0134
EpiControl
AF:
0.0135

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
2.2
DANN
Benign
0.52
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1062651; hg19: chr20-49508683; COSMIC: COSV62426339; COSMIC: COSV62426339; API